tiprankstipranks
Trending News
More News >
Chemomab Therapeutics (CMMB)
NASDAQ:CMMB

Compare Chemomab Therapeutics (CMMB) vs. Competitors

Compare
321 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Chemomab Therapeutics
$1.83
$11.02M
-0.98
-77.95%
2 Buy
0 Hold
0 Sell
Moderate Buy
Tenax Therapeutics
$14.70
$83.04M
-12.97
135.58%
4 Buy
0 Hold
0 Sell
Strong Buy
Q32 Bio
$3.64
$44.30M
-1.05
7.19%
1 Buy
1 Hold
0 Sell
Moderate Buy
Passage Bio
$17.91
$61.94M
-1.24
36.79%
4 Buy
0 Hold
0 Sell
Strong Buy
CalciMedica
$5.40
$84.30M
-3.36
76.49%
1 Buy
0 Hold
0 Sell
Moderate Buy
Longeveron
$0.63
$13.30M
-0.43
-64.80%
2 Buy
0 Hold
0 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
CMMB
Chemomab Therapeutics
1.83
-5.77
-75.92%
TENX
Tenax Therapeutics
14.70
8.27
128.62%
QTTB
Q32 Bio
3.64
0.57
18.57%
PASG
Passage Bio
17.91
5.97
50.00%
CALC
CalciMedica
5.40
2.39
79.40%
LGVN
Longeveron
0.57
-1.24
-68.45%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts